Institutions / Barclays PLC / Activity
Activity — Barclays PLC
49,937 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Q3 2025 as of | New | Biodesix, Inc. Common stock | $8 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | Exit | Biodesix, Inc. Common stock | $-8 | -1 -100.00% | 0 | low |
| Q3 2025 as of | New | 382140879 Common stock | $8 | +5 | 5 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 382140879 Common stock | $-8 | -5 -100.00% | 0 | low |
| Q1 2023 as of | Exit | 29978K110 Common stock | $-8 | -500 -100.00% | 0 | low |
| Q3 2025 as of | Exit | 92511W108 Common stock | $-8 | -16 -100.00% | 0 | low |
| Q2 2023 as of | Exit | 89610F101 Common stock | $-8 | -753 -100.00% | 0 | low |
| Q4 2024 as of | Exit | Minerva Neurosciences, Inc. Common stock | $-8 | -3 -100.00% | 0 | low |
| Q3 2024 as of | New | Minerva Neurosciences, Inc. Common stock | $8 | +3 | 3 0.00% of portfolio | low |
| Q2 2024 as of | Exit | Y6430L202 Common stock | $-8 | -3 -100.00% | 0 | low |
| Q1 2025 as of | New | BNGO Bionano Genomics, Inc. Common Stock | $8 | +3 | 3 0.00% of portfolio | low |
| Q2 2025 as of | Exit | BNGO Bionano Genomics, Inc. Common Stock | $-8 | -3 -100.00% | 0 | low |
| Q1 2025 as of | Add | MBOT Microbot Medical Inc. Common Stock | $8 | +5 +500.00% | 6 0.00% of portfolio | low |
| Q1 2025 as of | Trim | 04746L104 Common stock | $-9 | -34 -89.47% | 4 0.00% of portfolio | low |
| Q1 2024 as of | Trim | M97628107 Common stock | $-9 | -1 -0.01% | 7,839 <0.01% of portfolio | low |
| Q3 2023 as of | Add | 67421J108 Common stock | $9 | +10 +0.50% | 2,020 <0.01% of portfolio | low |
| Q4 2025 as of | Exit | 890023203 Common stock | $-9 | -9 -100.00% | 0 | low |
| Q3 2025 as of | New | 890023203 Common stock | $9 | +9 | 9 0.00% of portfolio | low |
| Q4 2024 as of | Exit | G63369105 Common stock | $-9 | -1 -100.00% | 0 | low |
| Q3 2024 as of | New | G63369105 Common stock | $9 | +1 | 1 0.00% of portfolio | low |
| Q1 2025 as of | New | RENT Rent the Runway, Inc. Common Stock | $9 | +2 | 2 0.00% of portfolio | low |
| Q3 2025 as of | New | 097235105 Common stock | $9 | +1 | 1 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 097235105 Common stock | $-9 | -1 -100.00% | 0 | low |
| Q3 2024 as of | Add | LSTA Lisata Therapeutics, Inc. Common Stock | $9 | +3 +75.00% | 7 0.00% of portfolio | low |
| Q4 2024 as of | Trim | LSTA Lisata Therapeutics, Inc. Common Stock | $-9 | -3 -42.86% | 4 0.00% of portfolio | low |
| Q3 2024 as of | New | Talphera, Inc. Common stock | $9 | +11 | 11 0.00% of portfolio | low |
| Q4 2024 as of | Exit | Talphera, Inc. Common stock | $-9 | -11 -100.00% | 0 | low |
| Q1 2023 as of | New | 03828A101 Common stock | $9 | +11 | 11 0.00% of portfolio | low |
| Q4 2023 as of | Trim | GDS GDS Holdings Ltd ADR | $-9 | -1 -0.00% | 87,018 <0.01% of portfolio | low |
| Q4 2024 as of | Trim | 405552100 Common stock | $-10 | -1 -0.07% | 1,499 <0.01% of portfolio | low |
| Q3 2025 as of | New | 126601103 Common stock | $10 | +3 | 3 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 126601103 Common stock | $-10 | -3 -100.00% | 0 | low |
| Q2 2023 as of | New | 343389102 Common stock | $10 | +14 | 14 0.00% of portfolio | low |
| Q3 2023 as of | Exit | 343389102 Common stock | $-10 | -14 -100.00% | 0 | low |
| Q2 2023 as of | Exit | GGB Gerdau S.A. ADR | $-10 | -2 -100.00% | 0 | low |
| Q4 2025 as of | Exit | LSTA Lisata Therapeutics, Inc. Common Stock | $-10 | -4 -100.00% | 0 | low |
| Q3 2025 as of | Exit | RENT Rent the Runway, Inc. Common Stock | $-10 | -2 -100.00% | 0 | low |
| Q2 2023 as of | Trim | 097702104 Common stock | $-10 | -8 -5.44% | 139 0.00% of portfolio | low |
| Q1 2023 as of | Add | 428304406 Common stock | $11 | +8 +0.02% | 38,984 <0.01% of portfolio | low |
| Q2 2024 as of | New | 863685202 Common stock | $11 | +6 | 6 0.00% of portfolio | low |
| Q4 2023 as of | New | 81727U105 Common stock | $11 | +20 | 20 0.00% of portfolio | low |
| Q4 2025 as of | Exit | 46265P107 Common stock | $-11 | -20 -100.00% | 0 | low |
| Q4 2025 as of | Exit | FLNT Fluent, Inc. Common Stock | $-11 | -5 -100.00% | 0 | low |
| Q3 2024 as of | Exit | WHWK Whitehawk Therapeutics, Inc. Common Stock | $-11 | -8 -100.00% | 0 | low |
| Q4 2025 as of | Exit | Creative Realities, Inc. Common stock | $-11 | -5 -100.00% | 0 | low |
| Q3 2025 as of | New | FLNT Fluent, Inc. Common Stock | $11 | +5 | 5 0.00% of portfolio | low |
| Q3 2025 as of | New | Creative Realities, Inc. Common stock | $11 | +5 | 5 0.00% of portfolio | low |
| Q3 2025 as of | New | 46265P107 Common stock | $11 | +20 | 20 0.00% of portfolio | low |
| Q2 2025 as of | Exit | 13803R300 Common stock | $-11 | -93 -100.00% | 0 | low |
| Q2 2025 as of | Exit | 83370P201 Common stock | $-11 | -12 -100.00% | 0 | low |